The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJDS.L Regulatory News (JDS)

  • There is currently no data for JDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

5 Mar 2020 09:21

RNS Number : 1288F
Jardine Matheson Hldgs Ltd
05 March 2020
 

Jardine Matheson Holdings Limited

Directorate Change

 

Jardine Matheson Holdings Limited (the 'Company') announces that, with effect from 15th June 2020, the roles of Executive Chairman and Managing Director, which have been held on a combined basis by Ben Keswick since December 2018, will revert to being separate roles.

 

Ben Keswick will remain as Executive Chairman and John Witt, currently Group Finance Director, will take on the role of Managing Director.

 

John joined Jardines in 1993 and held a range of senior roles across the Group's core businesses and geographies, including as chief financial officer of Hongkong Land and Mandarin Oriental, before being appointed to the Jardine Matheson Board in 2016.

 

John will also be a director of Jardine Strategic Holdings Limited and the Group's listed subsidiaries, Hongkong Land Holdings Limited, Dairy Farm International Holdings Limited and Mandarin Oriental International Limited. He will also continue to be a commissioner of Astra and chairman of the Astra Excom.

 

Graham Baker will replace John as Group Finance Director and will join the Group on 1st June 2020 from Smith + Nephew in the United Kingdom, where he has been a board member and chief financial officer since March 2017. Graham will join the Board of the Company.

 

Prior to joining Smith + Nephew, Graham worked for 20 years for AstraZeneca PLC in a range of senior roles in the UK and internationally, including in Japan and Singapore, and then as chief financial officer of generic pharmaceuticals company Alvogen.

 

Commenting on the changes, Ben Keswick said:

"I am confident that these appointments will strengthen and enhance the effectiveness of the Group's leadership as we respond to the challenges and opportunities we face in positioning Jardines for continuing long term success."

 

- end -

 

For further information please contact

 

Investor enquries:

Jonathan Lloyd

Jardine Matheson Limited

 

(852) 2843 8223

 

Media enquiries:

Brunswick

Tom Burns

 

(44) 207 404 5959

David Ashton

(852) 3512 5063

 

This and other Group announcements can be accessed at www.jardines.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUPUBAWUPUURA
Date   Source Headline
13th Apr 20218:03 amRNSSuspension of Listing of Jardine Strategic
12th Apr 20211:25 pmRNSUpdate on Simplification of JM & Acquisition of JS
12th Apr 20211:02 pmRNSResults of Special General Meeting
24th Mar 20219:35 amRNSDirector Declaration
18th Mar 20217:00 amRNSCir re. Publication of Shareholder Circular
11th Mar 202111:27 amRNS2020 Preliminary Announcement of Results
11th Mar 202111:23 amRNS2020 Preliminary Announcement of Results
11th Mar 20219:16 amRNS2020 Preliminary Announcement of Results
11th Mar 20219:16 amRNS2020 Preliminary Announcement of Results
11th Mar 20219:16 amRNS2020 Preliminary Announcement of Results
10th Mar 20219:38 amRNSFull Year 2020 Results of PT Hero
8th Mar 20217:00 amRNSSimplification of Jardine Matheson Structure
8th Mar 20217:00 amRNSRecommended Cash Acquisition of Jardine Strategic
26th Feb 202110:08 amRNSJardine Cycle & Carriage – Final Results
25th Feb 20219:54 amRNSAstra International - Final Results
5th Nov 20209:32 amRNSInterim Management Statement
5th Nov 20209:31 amRNSInterim Management Statement
5th Nov 20209:27 amRNSInterim Management Statement
5th Nov 20209:25 amRNSInterim Management Statement
5th Nov 20209:23 amRNSJC&C Interim Management Statement
5th Nov 20209:21 amRNSInterim Management Statement
30th Oct 202010:11 amRNSTotal Voting Rights
30th Oct 20209:24 amRNSNine Months 2020 Results of PT Hero
26th Oct 202010:38 amRNSPT Astra 2020 Third Quarter Financial Statements
14th Oct 202010:34 amRNSDirector/PDMR Shareholding
9th Oct 202010:23 amRNSAdditional Listing
30th Sep 202010:50 amRNSDividend
25th Sep 202011:39 amRNSDividend
2nd Sep 202010:24 amRNSCirc re. Scrip Dividend Scheme
30th Jul 202011:09 amRNSHalf-year Report
30th Jul 202011:03 amRNSHalf Year Results
30th Jul 202011:01 amRNSHalf-year Report
30th Jul 202010:36 amRNSJardine Cycle & Carriage - Half Year Results
29th Jul 202012:14 pmRNSHalf-year Report
29th Jul 202011:31 amRNSHalf-year Report
29th Jul 202010:53 amRNSFirst Half 2020 Results of PT Hero
29th Jul 202010:44 amRNSPT Astra International Tbk - First Half Results
15th Jun 202010:23 amRNSDirector Declaration
10th Jun 202010:27 amRNSFist Quarter 2020 Results of PT Hero
29th May 202010:24 amRNSTotal Voting Rights
13th May 202010:54 amRNSDirector/PDMR Shareholding
11th May 202010:24 amRNSAdditional Listing
7th May 202012:32 pmRNSAGM Statement
7th May 202012:32 pmRNSResult of AGM
29th Apr 202010:24 amRNSDividend
28th Apr 202010:38 amRNSInterim Management Statement
28th Apr 202010:37 amRNSInterim Management Statement
28th Apr 202010:28 amRNSInterim Management Statement
28th Apr 202010:20 amRNSInterim Management Statement
27th Apr 202010:55 amRNSJC&C Interim Management Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.